Correlation between financial relationships with commercial interests and research prominence at an oncology meeting

Journal of Clinical Oncology

Volumn 31, Issue 21, 2013, Pages 2678-2684

  Moy, Beverly ^a   Bradbury, Angela R ^b   Helft, Paul R ^d   Egleston, Brian L ^c   Sheikh Salah, Moktar ^e   Peppercorn, Jeffrey ^f  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; CONTROLLED STUDY; FINANCIAL MANAGEMENT; HUMAN; MEDICAL SOCIETY; ONCOLOGY; PEER REVIEW; PRIORITY JOURNAL; SYMPOSIUM; ECONOMICS; MEDICAL RESEARCH; ORGANIZATION; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL RESEARCH; FINANCIAL SUPPORT; HUMANS; MEDICAL ONCOLOGY; ORGANIZATIONAL AFFILIATION; PRIVATE SECTOR;

EID: 84890507064     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.46.6375     Document Type: Article

References (29)

1. Moy B: Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy. Oncologist 13:474-476, 2008
2. Sax JK: Financial conflicts of interest in science. Ann Health Law 21:291-327, 2012
3. Jones DJ, Barkun AN, Lu Y, et al: Conflicts of interest ethics: Silencing expertise in the development of international clinical practice guidelines. Ann Intern Med 156:809-816, 2012
4. Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289:454-465, 2003
5. Campbell EG, Moy B, Feibelmann S, et al: Institutional academic industry relationship: Results of interviews with university leaders. Account Res 11:103-118, 2004
6. Campbell EG, Weissman JS, Ehringhaus S, et al: Institutional academic industry relationships. JAMA 298:1779-1786, 2007
7. American Society of Clinical Oncology: American Society of Clinical Oncology: Revised conflict of interest policy. J Clin Oncol 24:519-521, 2006
8. Boyd EA, Cho MK, Bero LA: Financial conflict-of-interest policies in clinical research: Issues for clinical investigators. Acad Med 78:769-774, 2003
9. Lipton S, Boyd EA, Bero LA: Conflicts of interest in academic research: Policies, processes, and attitudes. Account Res 11:83-102, 2004
10. Lexchin J, Sekeres M, Gold J, et al: National evaluation of policies on individual financial conflicts of interest in Canadian academic health science centers. J Gen Intern Med 23:1896-1903, 2008
11. Hampson LA, Joffe S, Fowler R, et al: Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol 25:3609-3614, 2007
12. Peppercorn J, Blood E, Winer E, et al: Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer 109:1239-1246, 2007
13. Riechelmann RP, Wang L, O’Carroll A, et al: Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25:4642-4647, 2007
14. Krzyzanowska MK, Pintilie M, Tannock IF: Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290:495-501, 2003
15. Djulbegovic B, Lacevic M, Cantor A, et al: The uncertainty principle and industry-sponsored research. Lancet 356:635-638, 2000
16. Davidson RA: Source of funding and outcome of clinical trials. J Gen Intern Med 1:155-158, 1986
17. Easterbrook PJ, Berlin JA, Gopalan R, et al: Publication bias in clinical research. Lancet 337:867-872, 1991
18. Scherer RW, Dickersin K, Langenberg P: Full publication of results initially presented in abstracts: A meta-analysis. JAMA 272:158-162, 1994
19. Okike K, Kocher MS, Mehlman CT, et al: Conflict of interest in orthopaedic research: An association between findings and funding in scientific presentations. J Bone Joint Surg 89:608-613, 2007
20. Rochon PA, Sekeres M, Hoey J, et al: Investigator experiences with financial conflicts of interest in clinical trials. Trials 12:9, 2011
21. Lo B: Serving two masters: Conflicts of interest in academic medicine. N Engl J Med 362:669-671, 2010
22. Cho MK, Shohara R, Schissel A, et al: Policies on faculty conflicts of interest at US universities. JAMA 284:2203-2208, 2000
23. Okike K, Kocher MS, Wei EX, et al: Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 361:1466-1474, 2009
24. Cohen J: A power primer. Psychol Bull 112: 155-159, 1992
25. Bergstrom KA, Wang Z, Aksamit I, et al: Guideline adherence rates of chemotherapy treatment for breast cancer patients treated in U.S. community oncology practices. J Clin Oncol 28:91s, 2010 (suppl; abstr 596)
26. Burstein HJ, Piccart-Gebhart MJ, Perez EA, et al: Choosing the best trastuzumab-based adjuvant chemotherapy regimen: Should we abandon anthra-cyclines? J Clin Oncol 30:2179-2182, 2012
27. Hampson LA, Agrawal M, Joffe S, et al: Patients’ views on financial conflicts of interest in cancer research trials. N Engl J Med 355:2330-2337, 2006
28. Jagsi R, Sheets N, Jankovic A, et al: Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 115:2783-2791, 2009
29. Campbell EG, Weissman JS, Vogeli C, et al: Financial relationships between institutional review board members and industry. N Engl J Med 355: 2321-2329, 2006